Abstract
Although methylphenidate (Ritalin) has been used therapeutically for nearly 60 years, the mechanisms by which it acutely modifies behavioral performance are poorly understood. Here we combined intra–lateral amygdala in vivo pharmacology and ex vivo electrophysiology to show that acute administration of methylphenidate, as well as a selective dopamine transporter inhibitor, facilitated learning-induced strengthening of cortico-amygdala synapses through a postsynaptic increase in AMPA receptor–mediated currents, relative to those in saline-treated rats. Furthermore, local administration of methylphenidate in the lateral amygdala enhanced cue-reward learning through dopamine D1 receptor–dependent mechanisms and suppressed task-irrelevant behavior through D2 receptor–dependent mechanisms. These findings reveal critical and distinct roles for dopamine receptor subtypes in mediating methylphenidate-induced enhancements of neural transmission and learning performance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Swanson, J.M., Lerner, M. & Williams, L. More frequent diagnosis of attention deficit-hyperactivity disorder. N. Engl. J. Med. 333, 944 (1995).
Aman, M.G., Vamos, M. & Werry, J.S. Effects of methylphenidate in normal adults with reference to drug action in hyperactivity. Aust. N. Z. J. Psychiatry 18, 86–88 (1984).
American Psychiatric Association. ed. Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Publishing, Arlington, Virginia, USA, 1994).
Rodriguez, A. et al. Do inattention and hyperactivity symptoms equal scholastic impairment? Evidence from three European cohorts. BMC Public Health 7, 327 (2007).
Greenhill, L.L. et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J. Am. Acad. Child Adolesc. Psychiatry 41, 26S–49S (2002).
Yang, P., Chung, L.C., Chen, C.S. & Chen, C.C. Rapid improvement in academic grades following methylphenidate treatment in attention-deficit hyperactivity disorder. Psychiatry Clin. Neurosci. 58, 37–41 (2004).
LeDoux, J. The emotional brain, fear, and the amygdala. Cell. Mol. Neurobiol. 23, 727–738 (2003).
Tye, K.M., Stuber, G.D., de Ridder, B., Bonci, A. & Janak, P.H. Rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning. Nature 453, 1253–1257 (2008).
Cardinal, R.N., Parkinson, J.A., Hall, J. & Everitt, B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci. Biobehav. Rev. 26, 321–352 (2002).
Cador, M., Robbins, T.W. & Everitt, B.J. Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience 30, 77–86 (1989).
Davis, M. The role of the amygdala in emotional learning. Int. Rev. Neurobiol. 36, 225–266 (1994).
Schoenbaum, G., Chiba, A.A. & Gallagher, M. Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning. Nat. Neurosci. 1, 155–159 (1998).
Plessen, K.J. et al. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 63, 795–807 (2006).
Doron, N.N. & Ledoux, J.E. Organization of projections to the lateral amygdala from auditory and visual areas of the thalamus in the rat. J. Comp. Neurol. 412, 383–409 (1999).
Nakashima, M. et al. An anterograde and retrograde tract-tracing study on the projections from the thalamic gustatory area in the rat: distribution of neurons projecting to the insular cortex and amygdaloid complex. Neurosci. Res. 36, 297–309 (2000).
Reijmers, L.G., Perkins, B.L., Matsuo, N. & Mayford, M. Localization of a stable neural correlate of associative memory. Science 317, 1230–1233 (2007).
Han, J.H. et al. Selective erasure of a fear memory. Science 323, 1492–1496 (2009).
Tye, K.M. & Janak, P.H. Amygdala neurons differentially encode motivation and reinforcement. J. Neurosci. 27, 3937–3945 (2007).
Zheng, X., Liu, F., Wu, X. & Li, B. Infusion of methylphenidate into the basolateral nucleus of amygdala or anterior cingulate cortex enhances fear memory consolidation in rats. Sci. China C Life Sci. 51, 808–813 (2008).
Markowitz, J.S., DeVane, C.L., Pestreich, L.K., Patrick, K.S. & Muniz, R. A comprehensive in vitro screening of D-, L-, and DL-threo-methylphenidate: an exploratory study. J. Child Adolesc. Psychopharmacol. 16, 687–698 (2006).
Solanto, M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav. Brain Res. 94, 127–152 (1998).
Dougherty, D.D. et al. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354, 2132–2133 (1999).
Waldman, I.D. et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63, 1767–1776 (1998).
Volkow, N.D. et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. 21, RC121 (2001).
Volkow, N.D. et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155, 1325–1331 (1998).
Andersen, P.H. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166, 493–504 (1989).
Bissiere, S., Humeau, Y. & Luthi, A. Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition. Nat. Neurosci. 6, 587–592 (2003).
Malenka, R.C. & Nicoll, R.A. Long-term potentiation–a decade of progress? Science 285, 1870–1874 (1999).
Hess, G., Kuhnt, U. & Voronin, L.L. Quantal analysis of paired-pulse facilitation in guinea pig hippocampal slices. Neurosci. Lett. 77, 187–192 (1987).
Hitchcott, P.K., Harmer, C.J. & Phillips, G.D. Enhanced acquisition of discriminative approach following intra-amygdala d-amphetamine. Psychopharmacology (Berl.) 132, 237–246 (1997).
Bernal, S. et al. Role of amygdala dopamine D1 and D2 receptors in the acquisition and expression of fructose-conditioned flavor preferences in rats. Behav. Brain Res. 205, 183–190 (2009).
Hitchcott, P.K., Bonardi, C.M. & Phillips, G.D. Enhanced stimulus-reward learning by intra-amygdala administration of a D3 dopamine receptor agonist. Psychopharmacology (Berl.) 133, 240–248 (1997).
Touzani, K., Bodnar, R.J. & Sclafani, A. Dopamine D1-like receptor antagonism in amygdala impairs the acquisition of glucose-conditioned flavor preference in rats. Eur. J. Neurosci. 30, 289–298 (2009).
Andrzejewski, M.E., Spencer, R.C. & Kelley, A.E. Instrumental learning, but not performance, requires dopamine D1-receptor activation in the amygdala. Neuroscience 135, 335–345 (2005).
Lamont, E.W. & Kokkinidis, L. Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res. 795, 128–136 (1998).
Guarraci, F.A., Frohardt, R.J., Young, S.L. & Kapp, B.S. A functional role for dopamine transmission in the amygdala during conditioned fear. Ann. NY Acad. Sci. 877, 732–736 (1999).
Guarraci, F.A., Frohardt, R.J., Falls, W.A. & Kapp, B.S. The effects of intra-amygdaloid infusions of a D2 dopamine receptor antagonist on Pavlovian fear conditioning. Behav. Neurosci. 114, 647–651 (2000).
Greba, Q., Gifkins, A. & Kokkinidis, L. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Res. 899, 218–226 (2001).
Rosenkranz, J.A. & Grace, A.A. Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning. Nature 417, 282–287 (2002).
Kienast, T. et al. Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Nat. Neurosci. 11, 1381–1382 (2008).
Kroner, S., Rosenkranz, J.A., Grace, A.A. & Barrionuevo, G. Dopamine modulates excitability of basolateral amygdala neurons in vitro. J. Neurophysiol. 93, 1598–1610 (2005).
Loretan, K., Bissiere, S. & Luthi, A. Dopaminergic modulation of spontaneous inhibitory network activity in the lateral amygdala. Neuropharmacology 47, 631–639 (2004).
Marowsky, A., Yanagawa, Y., Obata, K. & Vogt, K.E. A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function. Neuron 48, 1025–1037 (2005).
Rosenkranz, J.A. & Grace, A.A. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J. Neurosci. 21, 4090–4103 (2001).
Moron, J.A., Brockington, A., Wise, R.A., Rocha, B.A. & Hope, B.T. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci. 22, 389–395 (2002).
Cornish, J.L. & Kalivas, P.W. Repeated cocaine administration into the rat ventral tegmental area produces behavioral sensitization to a systemic cocaine challenge. Behav. Brain Res. 126, 205–209 (2001).
Steketee, J.D. Repeated injection of GBR 12909, but not cocaine or WIN 35,065-2, into the ventral tegmental area induces behavioral sensitization. Behav. Brain Res. 97, 39–48 (1998).
Macedo, C.E., Martinez, R.C., Albrechet-Souza, L., Molina, V.A. & Brandao, M.L. 5-HT2- and D1-mechanisms of the basolateral nucleus of the amygdala enhance conditioned fear and impair unconditioned fear. Behav. Brain Res. 177, 100–108 (2007).
Berglind, W.J., Case, J.M., Parker, M.P., Fuchs, R.A. & See, R.E. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking. Neuroscience 137, 699–706 (2006).
See, R.E., Kruzich, P.J. & Grimm, J.W. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology (Berl.) 154, 301–310 (2001).
Acknowledgements
We thank H.L. Fields, G.D. Stuber, J.A. Rosenkranz and E.E. Steinberg for helpful comments; and A.C. Hollowell, S.L. Cho, S.J. Chang, L. Wang and F.W. Hopf for technical assistance. This research was supported by the State of California for Medical Research on Alcohol and Substance Abuse through the University of California at San Francisco (A.B. and P.H.J.), NIDA DA15096-01 (A.B.) and a Massachusetts Institute of Technology Peter J. Eloranta Summer Undergraduate Research Fellowship (L.D.T.).
Author information
Authors and Affiliations
Contributions
K.M.T. supervised experiments and performed all whole-cell recordings. K.M.T., A.B. and P.H.J. contributed to study design, results analysis, interpretation and manuscript writing. K.M.T., L.D.T., J.J.C. and E.F.H. surgically implanted guide cannulae, performed intra-LA drug infusions, conducted behavioral experiments, sectioned acute slice preparations and performed data entry and analyses. A.B. and P.H.J. provided mentorship and resources.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–19 (PDF 5850 kb)
Rights and permissions
About this article
Cite this article
Tye, K., Tye, L., Cone, J. et al. Methylphenidate facilitates learning-induced amygdala plasticity. Nat Neurosci 13, 475–481 (2010). https://doi.org/10.1038/nn.2506
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.2506
This article is cited by
-
Neurotensin orchestrates valence assignment in the amygdala
Nature (2022)
-
The stress–Wnt-signaling axis: a hypothesis for attention-deficit hyperactivity disorder and therapy approaches
Translational Psychiatry (2020)
-
Posterior basolateral amygdala to ventral hippocampal CA1 drives approach behaviour to exert an anxiolytic effect
Nature Communications (2020)
-
State-specific gating of salient cues by midbrain dopaminergic input to basal amygdala
Nature Neuroscience (2019)
-
Neurobiology of maternal regulation of infant fear: the role of mesolimbic dopamine and its disruption by maltreatment
Neuropsychopharmacology (2019)